Country Profile

Morocco

Morocco is a growing market for Indian pharmaceuticals — $113M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 69% of shipments, with vaccines contributing $10.1M. The compound annual growth rate since FY2015 stands at 13.7%.

🇲🇦 $113M · 4.1× growth since FY2015 · 13.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$113M
Exports FY2025–26 DGCIS
4.1×
Growth FY2015→2026
13.7%
CAGR FY2015→2026
69%
Medicines Share
5
Product Categories Supplied
Morocco is a growing market for Indian pharmaceuticals — $113M in FY 2025–26, with 4.1× growth over the past decade. Medicines accounts for 69% of shipments, with vaccines contributing $10.1M. The compound annual growth rate since FY2015 stands at 13.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $78.1M (69.0%) Medicine Ingredients $16.9M (15.0%) Vaccines $10.1M (8.9%) Surgical & Hospital Supplies $4.98M (4.4%) Traditional & Herbal $3.09M (2.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Morocco in the RBI overseas direct investment dataset (2011–2026).